✦ LIBER ✦
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma
✍ Scribed by David A. Reardon; Merrill J. Egorin; Annick Desjardins; James J. Vredenburgh; Jan H. Beumer; Theodore F. Lagattuta; Sridharan Gururangan; James E. Herndon II; August J. Salvado; Henry S. Friedman
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 297 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.